Investors
Information Disclosure
-
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE, 20232023.08.25
-
INTERIM DIVIDEND FOR 20232023.08.25
-
VOLUNTARY ANNOUNCEMENT - ENTERING INTO EXCLUSIVE LICENSE AND COOPERATION AGREEMENT WITH INVENTISBIO2023.08.03
-
NOTIFICATION OF BOARD MEETING2023.08.01
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 20232023.08.01
-
VOLUNTARY ANNOUNCEMENT - "TRASTUZUMAB INJECTION" APPROVED FOR LAUNCH TO MARKET2023.07.27
-
NEXT DAY DISCLOSURE RETURN2023.07.18
-
VOLUNTARY ANNOUNCEMENT - F-STAR ENTERED INTO STRATEGIC COLLABORATION AND LICENCE AGREEMENT WITH TAKEDA TO DISCOVER AND DEVELOP NEXT-GENERATION MULTI-SPECIFIC ANTIBODIES2023.07.05